Marker Therapeutics, Inc. MRKR

Set alert

Price alert · MRKR

All alert types
0.97 USD +0.07 +8.10%

As of Nov 3, 2:06 PM ET

Bid
0.97 × 6
Ask
0.98 × 6
0.8928 Day range 0.9741
0.84 52-week range 2.46
YTD
-34.62%
1 year
+1.47%
Open
0.9051
Prev close
0.9011
Mkt cap
16.24M
Vol
65.42K
Avg vol
111.66K
EPS
-0.42
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8928
High
0.9741
Forward P/E
-2.34
Beta
1.49
Short ratio
1.55
Inst. own
22.44%
Dividend
0.00
Ex-div date
Earnings
Mar 27, 2024
50-d avg
3.71
200-d avg
3.97
1y target
19.00

6M chart

Chart tools
Interval

Signals (29)
NameDateAgo
MACD: Sell SignalNov 2, 20261 day ago
MACD: Buy SignalOct 28, 20266 days ago
MACD: Sell SignalOct 27, 20261 week ago
SMA: BearishOct 20, 20262 weeks ago
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
MACD: Sell SignalSep 25, 20261 month ago
MACD: Buy SignalSep 23, 20261 month ago
MACD: Sell SignalSep 3, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BullishAug 21, 20262 months ago
MACD: Buy SignalAug 12, 20262 months ago
RSI: OversoldJul 29, 20263 months ago
MACD: Sell SignalJul 15, 20263 months ago
SMA: BearishJul 14, 20263 months ago
RSI: OverboughtJul 7, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago

Newest 20 of 29.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 19.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MRKR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.28-0.28 – -0.280.000.0%1.00M0.0%1
Next quarter-0.32-0.32 – -0.32-0.27-18.5%1.00M-19.6%1
Current year-1.05-1.05 – -1.050.000.0%5.34M0.0%1
Next year-2.19-2.19 – -2.19-1.05-108.6%4.00M-25.1%1

Upgrades and downgrades

The latest rating changes

MRKR analyst upgrades and downgrades
DateFirmActionFromTo
Apr 30, 2024Ladenburg ThalmannInitiated—Buy